Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet

Journal of Cardiology

Volumn 62, Issue 5, 2013, Pages 314-319

  Kobayashi, Yasuhiro ^a   Kumita, Shin ichiro ^a   Fukushima, Yoshimitsu ^a   Ishihara, Keiichi ^a   Suda, Masaya ^a   Sakurai, Minoru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Diagnostic techniques; Fluorodeoxyglucose; Positron emission tomography

Indexed keywords

FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIET RESTRICTION; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIVER; LOW CARBOHYDRATE DIET; LUNG; MALE; NORMAL HUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

DIAGNOSTIC TECHNIQUES; FLUORODEOXYGLUCOSE; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS;

EID: 84887166117     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.05.004     Document Type: Article

References (22)

1. Fukuchi K., Ohta H., Matsumura K., Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol 2007, 80:3-11.
2. Shreve P.D., Anzai Y., Wahl R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999, 19:61-77.
3. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012, 53:241-248.
4. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008, 35:933-941.
5. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011, 38:1773-1783.
6. Frayn K.N. The glucose-fatty acid cycle: a physiological perspective. Biochem Soc Trans 2003, 31:1115-1119.
7. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994, 93:2438-2446.
8. 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008, 190:W151-W156.
9. Harisankar C.N., Mittal B.R., Agrawal K.L., Abrar M.L., Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol 2011, 18:926-936.
10. 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol 2010, 17:286-291.
11. Kaneta T., Hakamatsuka T., Takanami K., Yamada T., Takase K., Sato A., Higano S., Kinomura S., Fukuda H., Takahashi S., Yamada S. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization. Ann Nucl Med 2006, 20:203-208.
12. de Groot M., Meeuwis A.P., Kok P.J., Corstens F.H., Oyen W.J. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005, 32:98-101.
13. 18F-FDG PET/CT. J Nucl Med 2007, 48:1662-1669.
14. Zorzano A., Santalucia T., Palacin M., Guma A., Camps M. Searching for ways to upregulate GLUT4 glucose transporter expression in muscle. Gen Pharmacol 1998, 31:705-713.
15. Armoni M., Harel C., Bar-Yoseph F., Milo S., Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem 2005, 280:34786-34795.
16. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983, 72:1737-1747.
17. McGarry J.D., Mannaerts G.P., Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977, 60:265-270.
18. Nowak B., Sinha A.M., Schaefer W.M., Koch K.C., Kaiser H.J., Hanrath P., Buell U., Stellbrink C. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003, 41:1523-1528.
19. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977, 63:86-108.
20. Fu Y., Maianu L., Melbert B.R., Garvey W.T. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis 2004, 32:182-190.
21. Sakamoto A., Nagai R., Saito K., Imai Y., Takahashi M., Hosoya Y., Takeda N., Hirano K., Koike K., Enomoto Y., Kume H., Homma Y., Maeda D., Yamada H., Fukayama M. Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis-retrospective analysis of 11 case histories. J Cardiol 2012, 59:139-146.
22. Ishizaka N., Sakamoto A., Imai Y., Terasaki F., Nagai R. Multifocal fibrosclerosis and IgG4-related disease involving the cardiovascular system. J Cardiol 2012, 59:132-138.